REQUEST A DEMO
Total
USD $0.00
Search more companies

Asiaprise Biotech Sdn. Bhd. (Malaysia)

Main Activities: Ambulatory Health Care Services
Full name: Asiaprise Biotech Sdn. Bhd. Profile Updated: October 16, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English Download a sample report

Asiaprise Biotech Sdn. Bhd. is a company in Malaysia, with a head office in Kuala Lumpur. The enterprise currently operates in the Ambulatory Health Care Services sector. It was first established on March 13, 1995. The company’s latest financial report indicates a net sales revenue increase of 10.2% in 2018. Over the same period, its total assets grew by 4.17%. The net profit margin of Asiaprise Biotech Sdn. Bhd. decreased by 7.04% in 2018.

Headquarters
Level 7, Menara Milenium, Jalan Damanlela, Pusat Bandar, Damansara, Damansara Heights
Kuala Lumpur; Federal Territories; Postal Code: 50490

Contact Details: Purchase the Asiaprise Biotech Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Asiaprise Biotech Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Asiaprise Biotech Sdn. Bhd. report to view the information.
Incorporation Date:
March 13, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
Subsidiaries
Asiaprise Pharma Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Asiaprise Biotech Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
10.2%
Total operating revenue
10.2%
Net Profit (Loss) for the Period
-72.2%
Total assets
4.17%
Total equity
1.83%
Net Profit Margin
-7.04%
Return on Equity (ROE)
-4.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?